DOCSLIB.ORG

Regulation of Antigen-Presenting Cell Function(S) in Lung and Airway Tissues

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Regulation of Antigen-Presenting Cell Function(S) in Lung and Airway Tissues Eur Respir J 1993, 6, 120-129 REVIEW Regulation of antigen-presenting cell function(s) in lung and airway tissues P.G. Holt Regulation of antigen-presenting cell function(s) in lung and airway tissues. Correspondence: P.G. Holt P.G. Holt. Division of Cell Biology ABSTRACT: A variety of cell populations present in respiratory tract tissues The Western Australian Research can express the function-associated molecules on their surface which are re­ Institute for Child Health quired for presentation of antigen to T-lymphocyte receptors. However, the GPO Box 0184 Perth, Western Australia 6001. potential role of individual cell populations in regulation of local T -lymphocyte· dependent immune reactions in the lung and airways depends on a variety of Keywords: Antigen presentation additional factors, including their precise localisation, migration characteris­ airway epithelium tics, expression ofT-cell "eo-stimulatory" signals, responsiveness to inflamma­ class li MHC (I a) antigen expression tory (in particular cytokine) stimuli, host immune status, and the nature of the T-lymphocyte activation antigen challenge. Recent evidence (reviewed below) suggests that tJ1e induc­ tion of primary immunity (viz. "sensitisation") to inhaled antigens is normally Received: April 30, 1992 controlled by specialised populations of Dendritic Cells, which perform a sur­ Accepted: September 8, 1992 veillance role within the epithelia of the upper and lower respiratory tract; in the pre-sensitised host, a variety of other cell populations (both bone-marrow derived and mesenchymal) may participate in re-stimulation of "memory" T­ lymphocytes. Eur Respir J .. 1993, 6, 120-129. Aberrant immunoinflammatory responses to exog­ control of T-cell activation is normally operative to enous antigens are important aetiological factors in a protect the lung against unnecessary and/or exagger­ large proportion of the common non-malignant respi­ ated responses to foreign antigens. ratory diseases. The inflammatory processes which produce the characteristic pathology in these diseases, are controlled directly or indirectly by the secreted Identification of APCs in respiratory tract tissues products ofT-cells, and result ultimately from a chain in situ: immunostaining of cells expressing class ll of cellular reactions initiated by the "presentation" of major histocompatibility complex (MHC) inhaled foreign antigen to the T-cell receptor. This immune region associated (la) antigen presentation event may occur locally, giving rise to im­ mediate activation of cytokine producing memory T­ Surface expression of Ia is a necessary prerequisite cells in the airway mucosa [1], and lumen [2), as has for "presentation" of antigen to the T-cell receptor, been observed in chronic asthmatics, or systemically, and, in general terms, the concentration of la on the particularly in the regional lymph nodes draining the cell surface correlates with the potency of APCs in respiratory tract, where initial "priming" of the naive T-cell activation l4J. Thus, potential APCs may be immune system occurs following inhalation of antigens identified in tissue sections by immunoenzymatic stain­ not previously encountered [3). ing employing monoclonal antibodies against la. The immunological sequelae of these initial T -cell A substantial literature is available from studies which activation events are highly variable and can range have applied this technology to lung tissue. from T-cell anergy or tolerance, to the manifestations Cells expressing la are abundant in lung tissues of of hypersensitivity and associated tissue pathology. all speci.es examined, and are found both within epi­ The eventual outcome of individual encounters with thelial and submucosal sites throughout the conduct­ inhaled antigens depends to a significant extent on the ing airways, and within the connective tissues functional capacity of the antigen-presenting cells sur- rounding blood vessels and alveolar septal walls (APCs), which initially sequester the antigens. Recent in the lung parenchyma. The precise identity of information on the nature of APC populations in dif­ immuno-stained cells in lung tissue sections has been ferent tissue microenvironments in the respiratory tract, understandably controversial, in view of the difficul­ reviewed below, suggests that a high level of local ties associated with controlling the plane of section; REGULATION OF APC FUNCTION IN AIRWAYS 121 particularly with small biopsy samples from human co-stimulator(s) by DCs is constitutive [8, 9), whereas lung. Interpretation of the human literature is further­ macrophages and B-cells produce Httle, unless they are complicated by the paucity of data on normal control pre-stimulated with natural "adjuvants", in particular tissue. bacterial cell wall antigens conttlining lipopolysaccha­ At least seven major cell types have been positively ride [8]. Mesenchymal cells, such as epithelia and identified as expressing la in healthy or diseased lungs: fibroblasts, are believed to be generally incapable of B-lymphocytes, activated T-lymphocytes, fibroblasts, delivering an effective co-stimul.ator signal [ 10], dendritic cells (DCs), and macrophages - the latter although this issue is controversial. can be further subdivided (only in humans) into resi­ Host immune status is also an important determinant dent pulmonary alveolar macrophages (PAMs), infil­ in selecdon of appropriate APCs. It is now recognized trating monocytes present in either extraceilular fluids that naive (i.e. non-immune) and memory-T-cells have on the alveolar surface or within solid ti ssues, and ma­ different requirements for anligen-specific activation. ture tissue macrophages. With the exception of la+T­ In particular, with respect to soluble protein antigens, Iymphoblasts, all of Lllese latter cells have been monocytes/macrophages and B-cells funcrion very invoked as potential regulators of antigen specific T­ poorly in presentation of inductive signals to naive T­ cell responses to inhaled antigens, and the salient as­ cells. whereas they effecrively stimulate responses in pects of rhe supporting evidence for these claims is memory T-cells [9, 11 , 12, 13]. DCs appear unique reviewed below. in their capacity to present soluble protein antigens to non-immune T-cells [9J and hence prime/sensitize the naive host. Factors determining the contribution of potential The situation with respect to the induction of pri­ APC populations to individual immune responses mary immunity to particulate antigens is less cle~u·, as in the lung DCs are actively endocytic. but appear non-phagocytic The cell populations detailed above ctul be broadly in vitro L9). However. at the ultrastrucrural level, c lassified as "professional" APCs (B-cells, mature DCs exhibit cytoplasmic inclusions character­ macrophages and DCs) or "opportunistic" APCs (air­ istic of secondary lysozomes, prompting suggestions of wHy epithelial cell s . Type ll pneumocytes and phagocytic activity al an earlier stage of their life fibroblasts). The potential for each cell population to cycle in vivo [14]. participate in an immune induction event in the respi­ Based on the above, our current understanding of the ratory tract is determined by two sets of interacting role of the various candidate APCs is outlined below. factors: hos t· immune status, and the physicochemi­ cal properties of the inhaled antigen. APC populations in normal lung It is axiomatic that large insoluble particulate anti­ gens will gain only limited access to cell populations Dendritic cells below epithelial surfaces, and hence U1e transmission of antigenic signals to the T-cells system from such The presence of DCs in human parenchyma] lung sources requires the participation of actively phagocytic tissue was initially associated with underlying inflam­ cells, which function at the level of L11 e airway matory and fibrotic disease states [15. 16]. However, lumenal suli'ace. Moreover. the relevam APC requires they were subsequently identified as normal residents the additional capacity to migrate selectively to T-cell of the uirway epithelium and alveolar septa in all spe­ zones in regional lymph nodes, in order to induce a cies [17-20]. primary immune response in a naive host. The first evidence of a role for these cells in anti­ In contrast, low molecular weight soluble antigens, gen presentation to T-lymphocytes, was provided by may be expected to be readily translocated to intra­ a study on rat lung from our laboratory [211. These epithelial or submucosal. microenvironments via intrn­ experiments employed collagenase digestion to extract ceUular (pinocytic) or imercellular pathways [5], and mononuclear cells from lung parenchyma) tissue, prior hence gain access to all the potential APC populations to assessment of APC activity in various cell fractions listed above. This class of antigen, typified by Dcr of the digest. The phenotype of Lh e principal APC in p I allergen from the house dust mite. which leaches lhese digests was non-adherent, non-phagocytic, sur­ rapidly into epithelial lining nuids after impaction on face immunoglobulin (slg-), la• and of ultra-low den­ the airway surface [6], appears particularly effective in sity on percoiJ gradients, consistent wilh their identity inducing immunologically-mediated disease. as DCs L21]. These results were confirmed and ex­ A further factor of importance, relates to the capac­ tended to include an identical population in the airway ity of individual antigens to directly "stimulate" aspects epithelium
Load more

Recommended publications
  • Severe COVID-19: Understanding the Role of Immunity, Endothelium, and Coagulation in Clinical Practice
    ARTIGO DE REVISÃO ISSN 1677-7301 (Online) COVID-19 grave: entenda o papel da imunidade, do endotélio e da coagulação na prática clínica Severe COVID-19: understanding the role of immunity, endothelium, and coagulation in clinical practice Simone Cristina Soares Brandão1 , Emmanuelle Tenório Albuquerque Madruga Godoi1 , Júlia de Oliveira Xavier Ramos1 , Leila Maria Magalhães Pessoa de Melo2 , Emanuel Sávio Cavalcanti Sarinho1 Resumo O SARS-CoV-2 é o responsável pela pandemia da COVID-19. O sistema imunológico é fator determinante no combate à infecção viral e, quando atua equilibrada e eficientemente, a doença é autolimitada e benigna. Uma parcela significativa da população, porém, apresenta resposta imune exacerbada. Os indivíduos diabéticos, hipertensos, obesos e com doenças cardiovasculares, infectados pelo vírus, apresentam maior chance de progredir para formas graves. Essas doenças estão relacionadas a processos inflamatórios crônicos e disfunção endotelial. Os receptores do tipo Toll estão presentes nas células de defesa e participam da imunopatologia de doenças cardiovasculares e metabólicas, levando à produção de citocinas pró-inflamatórias quando ativados. Devido à ação viral e à hiperativação do sistema imune, estados de hiperinflamação, hiperativação plaquetária, disfunção endotelial e hipercoagulabilidade são desenvolvidos, predispondo a tromboses venosas e arteriais. Discutiremos sobre a interação entre a COVID-19, a imunidade, o endotélio e a coagulação, como também sobre as possíveis causas de doenças cardiometabólicas impactarem negativamente na evolução da COVID-19. Palavras-chave: COVID-19; endotélio; imunidade; aterosclerose; trombose. Abstract SARS-CoV-2 is responsible for the COVID-19 pandemic. The immune system is a determinant factor in defense against viral infections. Thus, when it acts in a balanced and effective manner the disease is self-limited and benign.
    [Show full text]
  • Regulation of Macrophage Development and Function in Peripheral Tissues
    REVIEWS Regulation of macrophage development and function in peripheral tissues Yonit Lavin, Arthur Mortha, Adeeb Rahman and Miriam Merad Abstract | Macrophages are immune cells of haematopoietic origin that provide crucial innate immune defence and have tissue-specific functions in the regulation and maintenance of organ homeostasis. Recent studies of macrophage ontogeny, as well as transcriptional and epigenetic identity, have started to reveal the decisive role of the tissue stroma in the regulation of macrophage function. These findings suggest that most macrophages seed the tissues during embryonic development and functionally specialize in response to cytokines and metabolites that are released by the stroma and drive the expression of unique transcription factors. In this Review, we discuss how recent insights into macrophage ontogeny and macrophage–stroma interactions contribute to our understanding of the crosstalk that shapes macrophage function and the maintenance of organ integrity. Mononuclear phagocyte Macrophages are key components of the innate immune characterized the transcriptional and epigenetic pro- system system that reside in tissues, where they function as grammes of tissue-resident macrophages and revealed (MPS). A group of bone immune sentinels. They are uniquely equipped to sense the extent of diversity in these populations1,8. In addi- marrow-derived cells and respond to tissue invasion by infectious microorgan- tion to differences in ontogeny, locally derived tissue (monocytes, macrophages and isms and tissue
    [Show full text]
  • Intestinal Epithelial Cell Regulation of Adaptive Immune Dysfunction in Human Type 1 Diabetes
    ORIGINAL RESEARCH published: 10 January 2017 doi: 10.3389/fimmu.2016.00679 Intestinal Epithelial Cell Regulation of Adaptive Immune Dysfunction in Human Type 1 Diabetes Christina L. Graves1, Jian Li2, Melissa LaPato1, Melanie R. Shapiro1, Sarah C. Glover 2, Mark A. Wallet3 and Shannon M. Wallet1* 1 Department of Oral Biology, College of Dentistry, University of Florida Health Science Center, Gainesville, FL, USA, 2 Department of Gastroenterology, Hepatology, and Nutrition, College of Medicine, University of Florida Health Science Center, Gainesville, FL, USA, 3 Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida Health Science Center, Gainesville, FL, USA Environmental factors contribute to the initiation, progression, and maintenance of type 1 diabetes (T1D), although a single environmental trigger for disease has not been iden- tified. Studies have documented the contribution of immunity within the gastrointestinal tract (GI) to the expression of autoimmunity at distal sites. Intestinal epithelial cells (IECs) regulate local and systemic immunologic homeostasis through physical and biochemical interactions with innate and adaptive immune populations. We hypothesize that a loss in the tolerance-inducing nature of the GI tract occurs within T1D and is due to altered IECs’ Edited by: innate immune function. As a first step in addressing this hypothesis, we contrasted the Olivier Garraud, global immune microenvironment within the GI tract of individuals with T1D as well as Institut National de la Transfusion Sanguine, France evaluated the IEC-specific effects on adaptive immune cell phenotypes. The soluble and Reviewed by: cellular immune microenvironment within the duodenum, the soluble mediator profile of Nicolas Riteau, primary IECs derived from the same duodenal tissues, and the effect of the primary IECs’ National Institutes of Health, USA soluble mediator profile on T-cell expansion and polarization were evaluated.
    [Show full text]
  • The Systemic Inflammation of Alveolar Hypoxia Is Initiated by Alveolar
    The Systemic Inflammation of Alveolar Hypoxia Is Initiated by Alveolar Macrophage–Borne Mediator(s) Jie Chao1, John G. Wood1, Victor Gustavo Blanco1, and Norberto C. Gonzalez1 1Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas Alveolar hypoxia produces widespread systemic inflammation in rats. The inflammation appears to be triggered by activation of mast CLINICAL RELEVANCE cells by a mediator released from alveolar macrophages, not by the reduced systemic partial pressure of oxygen (PO2). If this is correct, This study demonstrates a direct link, via a circulating the following should apply: (1) neither mast cells nor tissue macro- mediator, between activation of alveolar macrophages by phages should be directly activated by hypoxia; and (2) mast cells low alveolar PO2, and degranulation of systemic mast cells, should be activated when in contact with hypoxic alveolar macro- the first step in the systemic inflammatory cascade. A phages, but not with hypoxic tissue macrophages. We sought here to candidate mediator, monocyte chemoattractant protein-1, determine whether hypoxia activates isolated alveolar macro- was identified. Roles of low tissue PO2 and activation of phages, peritoneal macrophages, and peritoneal mast cells, and to tissue macrophages were ruled out. The phenomenon study the response of the microcirculation to supernatants of these described could participate in the inflammation underlying cultures. Rat mesenteric microcirculation intravital microscopy was the systemic effects seen in conditions associated with low combined with primary cultures of alveolar macrophages, peritoneal alveolar PO2. macrophages, and peritoneal mast cells. Supernatant of hypoxic alveolar macrophages, but not of hypoxic peritoneal macrophages, produced inflammation in mesentery.
    [Show full text]
  • View Open Access Alveolar Hypoxia, Alveolar Macrophages, and Systemic Inflammation Jie Chao, John G Wood and Norberto C Gonzalez*
    Respiratory Research BioMed Central Review Open Access Alveolar hypoxia, alveolar macrophages, and systemic inflammation Jie Chao, John G Wood and Norberto C Gonzalez* Address: Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA Email: Jie Chao - [email protected]; John G Wood - [email protected]; Norberto C Gonzalez* - [email protected] * Corresponding author Published: 22 June 2009 Received: 2 April 2009 Accepted: 22 June 2009 Respiratory Research 2009, 10:54 doi:10.1186/1465-9921-10-54 This article is available from: http://respiratory-research.com/content/10/1/54 © 2009 Chao et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Diseases featuring abnormally low alveolar PO2 are frequently accompanied by systemic effects. The common presence of an underlying inflammatory component suggests that inflammation may contribute to the pathogenesis of the systemic effects of alveolar hypoxia. While the role of alveolar macrophages in the immune and defense functions of the lung has been long known, recent evidence indicates that activation of alveolar macrophages causes inflammatory disturbances in the systemic microcirculation. The purpose of this review is to describe observations in experimental animals showing that alveolar macrophages initiate a systemic inflammatory response to alveolar hypoxia. Evidence obtained in intact animals and in primary cell cultures indicate that alveolar macrophages activated by hypoxia release a mediator(s) into the circulation.
    [Show full text]
  • Human Tumor-Infiltrating Dendritic Cells: from in Situ Visualization To
    cancers Review Human Tumor-Infiltrating Dendritic Cells: From In Situ Visualization to High-Dimensional Analyses Margaux Hubert y, Elisa Gobbini y, Nathalie Bendriss-Vermare , Christophe Caux and Jenny Valladeau-Guilemond * Cancer Research Center Lyon, UMR INSERM 1052 CNRS 5286, Centre Léon Bérard, 28 rue Laennec, 69373 Lyon, France * Correspondence: [email protected]; Tel.: +33-(0)4-78-78-29-64 Joint first author. y Received: 20 June 2019; Accepted: 22 July 2019; Published: 30 July 2019 Abstract: The interaction between tumor cells and the immune system is considered to be a dynamic process. Dendritic cells (DCs) play a pivotal role in anti-tumor immunity owing to their outstanding T cell activation ability. Their functions and activities are broad ranged, triggering different mechanisms and responses to the DC subset. Several studies identified in situ human tumor-infiltrating DCs by immunostaining using a limited number of markers. However, considering the heterogeneity of DC subsets, the identification of each subtype present in the immune infiltrate is essential. To achieve this, studies initially relied on flow cytometry analyses to provide a precise characterization of tumor-associated DC subsets based on a combination of multiple markers. The concomitant development of advanced technologies, such as mass cytometry or complete transcriptome sequencing of a cell population or at a single cell level, has provided further details on previously identified populations, has unveiled previously unknown populations, and has finally led to the standardization of the DCs classification across tissues and species. Here, we review the evolution of tumor-associated DC description, from in situ visualization to their characterization with high-dimensional technologies, and the clinical use of these findings specifically focusing on the prognostic impact of DCs in cancers.
    [Show full text]
  • Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps
    biomolecules Review Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps Brandon Bautista-Becerril 1,2,†, Rebeca Campi-Caballero 2,3,†, Samuel Sevilla-Fuentes 4, Laura M. Hernández-Regino 5, Alejandro Hanono 6 , Al Flores-Bustamante 7, Julieta González-Flores 2 , Carlos A. García-Ávila 5 , Arnoldo Aquino-Gálvez 8 , Manuel Castillejos-López 9 , Armida Juárez-Cisneros 1 and Angel Camarena 1,* 1 Laboratorio HLA, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico; [email protected] (B.B.-B.); [email protected] (A.J.-C.) 2 Programa MEDICI, Carrera Médico Cirujano, FES Iztacala, Universidad Nacional Autónoma de México, Mexico City 54090, Mexico; [email protected] (R.C.-C.); [email protected] (J.G.-F.) 3 Laboratorio de Neuropsicofarmacología, Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico 4 Departamento de Infectología, Hospital General de México Eduardo Liceaga, Mexico City 06720, Mexico; [email protected] 5 Escuela Nacional de Ciencias Biológicas, Programa de Posgrado, Instituto Politécnico Nacional, Mexico City 11340, Mexico; [email protected] (L.M.H.-R.); [email protected] (C.A.G.-Á.) Citation: Bautista-Becerril, B.; 6 Facultad de Ciencias de la Salud, Universidad Anáhuac México Norte, Mexico City 52786, Mexico; Campi-Caballero, R.; Sevilla-Fuentes, [email protected] S.; Hernández-Regino, L.M.; Hanono, 7 Laboratorio de Farmacología, Instituto
    [Show full text]
  • Modulation of Cell-Mediated Immunity by HIV-1 Infection of Macrophages
    Modulation of cell-mediated immunity by HIV-1 infection of macrophages Lucy Caitríona Kiernan Bell Division of Infection and Immunity University College London PhD Supervisor: Dr Mahdad Noursadeghi A thesis submitted for the degree of Doctor of Philosophy University College London August 2014 Declaration I, Lucy Caitríona Kiernan Bell, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Abstract Cell-mediated immunity (CMI) is central to the host response to intracellular pathogens such as Mycobacterium tuberculosis (Mtb). The function of CMI can be modulated by human immunodeficiency virus (HIV)-1 via its pleiotropic effects on the immune response, including modulation of macrophages, which are parasitized by both HIV-1 and Mtb. HIV-1 infection is associated with increased risk of tuberculosis (TB), and so in this thesis I sought to explore the host/pathogen interactions through which HIV-1 dysregulates CMI, and thus changes the natural history of TB. Using an in vitro model of human monocyte-derived macrophages (MDMs), I characterise a phenotype wherein HIV-1 specifically attenuates production of the immunoregulatory cytokine interleukin (IL)-10 in response to Mtb and other innate immune stimuli. I show that this phenotype requires HIV-1 integration and gene expression, and may result from a function of the HIV-1 accessory proteins. I identify that the phosphoinositide 3-kinase (PI3K) pathway specifically regulates IL-10 production in human MDMs, and thus may be a target for HIV-1 to mediate IL-10 attenuation.
    [Show full text]
  • Cross Talk Between Natural Killer Cells and Mast Cells in Tumor Angiogenesis
    Inflammation Research (2019) 68:19–23 https://doi.org/10.1007/s00011-018-1181-4 Inflammation Research REVIEW Cross talk between natural killer cells and mast cells in tumor angiogenesis Domenico Ribatti1 · Roberto Tamma1 · Enrico Crivellato2 Received: 5 July 2018 / Revised: 13 August 2018 / Accepted: 16 August 2018 / Published online: 21 August 2018 © Springer Nature Switzerland AG 2018 Abstract Natural killer (NK) cells are large granular lymphocytes of the innate immune system, responsible for direct targeting and killing of both virally infected and transformed cells. Under pathological conditions and during inflammation, NK cells extravasate into the lymph nodes and accumulate at inflammatory or tumor sites. The activation of NK cells depends on an intricate balance between activating and inhibitory signals that determines if a target will be susceptible to NK-mediated lysis. Many experimental evidences indicate that NK cells are also involved in several immunoregulatory processes and have the ability to modulate the adaptive immune responses. Many other important aspects about NK cell biology are emerging in these last years. The aim of this review is to elucidate the role of NK cells in tumor angiogenesis and their interaction with mast cells. In fact, it has been observed that NK cells produce pro-angiogenic factors and participate alone or in coopera- tion with mast cells to the regulation of angiogenesis in both physiological and pathological conditions including tumors. Keywords Angiogenesis · Anti-angiogenesis · Mast cells · NK cells · Tumor growth NK cell distribution in healthy tissues are found in the blood circulation, where they express high amounts of CD16 and low amounts of CD56 (or NCAM, Natural killer (NK) cells originate from hematopoietic stem neural cell adhesion molecule), while other NK cells express cells (HSC) and undergo maturation primarily in the bone high amounts of CD56, lack of CD16, and have low cyto- marrow, where stromal cells produce factors sustaining pro- toxic activity [5].
    [Show full text]
  • Differential Role of Neutrophils and Alveolar Macrophages In
    0023-6837/02/8208-1015$03.00/0 LABORATORY INVESTIGATION Vol. 82, No. 8, p. 1015, 2002 Copyright © 2002 by The United States and Canadian Academy of Pathology, Inc. Printed in U.S.A. Differential Role of Neutrophils and Alveolar Macrophages in Hepatocyte Growth Factor Production in Pulmonary Fibrosis Bruno Crestani, Monique Dehoux, Gilles Hayem, Véronique Leçon, Francine Hochedez, Joëlle Marchal, Sandrine Jaffré, Jean-Baptiste Stern, Geneviève Durand, Dominique Valeyre, Michel Fournier, and Michel Aubier INSERM Unit 408 (BC, MD, JM, SJ, J-BS, MF, MA), Faculté Xavier Bichat, and Laboratoire de Biochimie A (MD, VL, FH, GD), Service de Pneumologie (BC, MA), and Service de Rhumatologie (GH), Hôpital Bichat, Paris, and Service de Pneumologie (MF), Hôpital Beaujon, Clichy, and Service de Pneumologie (DV), Hôpital Avicenne, Bobigny, Assistance Publique-Hôpitaux de Paris, France SUMMARY: Neutrophils may participate in the development of lung fibrosis. Hepatocyte growth factor (HGF), a growth factor for type II pneumocytes, is produced by neutrophils. We measured the production of HGF by blood and alveolar neutrophils from patients with either idiopathic pulmonary fibrosis (n ϭ 11) or connective tissue disease-associated pulmonary fibrosis (n ϭ 10) and from control patients (n ϭ 10). HGF secretion by alveolar macrophages and the expression of the HGF receptor by alveolar epithelial cells in pulmonary fibrosis were also evaluated. HGF was not detected in bronchoalveolar lavage fluid from controls. HGF concentration in the epithelial lining fluid from patients was 4-fold higher than in plasma, suggesting a local production within the alveolar space. Alveolar neutrophils secreted HGF in vitro. Basal HGF secretion by alveolar neutrophils positively correlated with HGF in the epithelial lining fluid (p ϭ 0.05, rho ϭ 0.582).
    [Show full text]
  • Effect of Erythrocytes on Alveolar Macrophage Cytostatic Activity Induced by Bleomycin Lung Damage in Rats'
    (CANCER RESEARCH 50. 2351-2355. April 15. I Effect of Erythrocytes on Alveolar Macrophage Cytostatic Activity Induced by Bleomycin Lung Damage in Rats' Anne K. Huot, R. Mary Gundel, and Miles P. Hacker2 Department oj Pharmacology and the l'emioni Regional Cancer (enter, I 'nirersity of \ 'emioni, fiiirlington, I emioni 1)5405 ABSTRACT Although the exact mechanism of this toxicity is poorly under stood, it is known that BLM, whether administered i.v. as in Bleomycin (BLM) has been successfully used to treat a number of the clinic or i.t. as in many experimental protocols, causes an human neoplasms. The main toxicity associated with BLM therapy is an alveolitis that precedes fibrosis (6, 7). acute pulmonary inflammation that can culminate in diffuse chronic fibrosis. I In- effect of BI.M-induced pulmonary inflammation on the We, as well as others, have shown that when BLM is admin cytostatic activity of alveolar macrophages (AM) »asinvestigated using istered i.t. there are two distinct phases of the disease (8, 9). AM obtained from rats that had been previously treated with BLM. Initially, there is an acute inflammation characterized by an Bronchoalveolar lavage fluid was collected at selected time intervals influx of inflammatory cells and selected proteins into the following a single fibrogcnic dose of intratracheally administered BLM alveolar space. Subsequently, there is a period of more chronic (3.6 mg/kg). AM obtained 12 to 72 h following intratrachcal Iti M disease, during which the acute inflammation subsides and the (BLM-AM) caused cytostasis of murine leukemia L1210 cells in co- laying down of fibrotic tissue begins.
    [Show full text]
  • Monocyte and Macrophage Heterogeneity
    REVIEWS MONOCYTE AND MACROPHAGE HETEROGENEITY Siamon Gordon and Philip R. Taylor Abstract | Heterogeneity of the macrophage lineage has long been recognized and, in part, is a result of the specialization of tissue macrophages in particular microenvironments. Circulating monocytes give rise to mature macrophages and are also heterogeneous themselves, although the physiological relevance of this is not completely understood. However, as we discuss here, recent studies have shown that monocyte heterogeneity is conserved in humans and mice, allowing dissection of its functional relevance: the different monocyte subsets seem to reflect developmental stages with distinct physiological roles, such as recruitment to inflammatory lesions or entry to normal tissues. These advances in our understanding have implications for the development of therapeutic strategies that are targeted to modify particular subpopulations of monocytes. OSTEOCLAST Circulating monocytes give rise to a variety of tissue- elicit increased recruitment of monocytes to peripheral A multinucleate cell that resident macrophages throughout the body, as well as sites4, where differentiation into macrophages and DCs resorbs bone. to specialized cells such as dendritic cells (DCs) and occurs, contributing to host defence, and tissue remod- OSTEOCLASTS. Monocytes are known to originate in the elling and repair. Studies of the mononuclear-phagocyte bone marrow from a common myeloid progenitor that system, using monoclonal antibodies specific for vari- is shared with neutrophils, and they are then released ous cell-surface receptors and differentiation antigens, into the peripheral blood, where they circulate for have shown that there is substantial heterogeneity of several days before entering tissues and replenishing phenotype, which most probably reflects the special- the tissue macrophage populations1.
    [Show full text]